Comparison of high- and low-dose corticosteroid regimens for organ donor management

Journal of Critical Care

Volumn 28, Issue 1, 2013, Pages 111.e1-111.e7

  Dhar, Rajat ^a   Cotton, Colleen ^a   Coleman, Jason ^b   Brockmeier, Diane ^b   Kappel, Dean ^b   Marklin, Gary ^c   Wright, Robert ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mid America Transplant Services   (United States)

^c St Anthony's Medical Center   (United States)

^d SSM St Mary's Health Center   (United States)

Author keywords

Brain death; Glucocorticoids; Heart transplantation; Hyperglycemia; Lung transplantation; Organ procurement

Indexed keywords

GLUCOSE; HYDROCORTISONE; HYPERTENSIVE AGENT; INSULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRAIN DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INSULIN INFUSION; LOW DRUG DOSE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OXYGEN TENSION; SINGLE DRUG DOSE; TISSUE OXYGENATION;

EID: 84870785334     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.04.015     Document Type: Article

References (27)

1. Venkateswaran R.V., Dronavalli V., Lambert P.A., et al. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation 2009, 88(4):582-588.
2. Avlonitis V.S., Wigfield C.H., Kirby J.A., Dark J.H. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005, 5(4 Pt 1):684-693.
3. Pratschke J., Wilhelm M.J., Kusaka M., et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999, 67(3):343-348.
4. Dimopoulou I., Tsagarakis S., Anthi A., et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 2003, 31(4):1113-1117.
5. Rosengard B.R., Feng S., Alfrey E.J., et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002, 2(8):701-711.
6. Novitzky D., Cooper D.K.C., Rosendale J.D., Kauffman H.M. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 2006, 82(11):1396-1401.
7. Follette D.M., Rudich S.M., Babcock W.D. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998, 17(4):423-429.
8. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003, 75(4):482-487.
9. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003, 75(8):1336-1341.
10. Wheeldon D.R., Potter C.D., Oduro A., et al. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995, 14(4):734-742.
11. Blasi-Ibanez A., Hirose R., Feiner J., et al. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology 2009, 110(2):333-341.
12. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26(4):645-650.
13. Annane D., Sébille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
14. Oppert M., Schindler R., Husung C., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33(11):2457-2464.
15. Briegel J., Jochum M., Gippner-Steppert C., Thiel M. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 2001, 12(Suppl. 1):S70-S74.
16. Metzger R.A., Delmonico F.L., Feng S., et al. Expanded criteria donors for kidney transplantation. Am J Transplant 2003, 3(Suppl. 4):114-125.
17. Kucirka L.M., Namuyinga R., Hanrahan C., et al. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 2009, 9(3):629-635.
18. Straznicka M., Follette D.M., Eisner M.D., et al. Aggressive management of lung donors classified as unacceptable: Excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002, 124(2):250-258.
19. Venkateswaran R.V., Patchell V.B., Wilson I.C., et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008, 85(1):278-286.
20. Venkateswaran R.V., Steeds R.P., Quinn D.W., et al. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J 2009, 30(14):1771-1780.
21. Nath D.S., Ilias Basha H., Liu M.H., et al. Increased recovery of thoracic organs after hormonal resuscitation therapy. J Heart Lung Transplant 2010, 29(5):594-596.
22. Nicolas-Robin A., Barouk J.D., Amour J., et al. Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients. Anesthesiology 2010, 112(5):1204-1210.
23. Egi M., Bellomo R., Stachowski E., et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008, 36(8):2249-2255.
24. Vlasselaers D., Mesotten D., Langouche L., et al. Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg 2010, 90(1):22-29.
25. Masson F., Thicoipe M., Gin H., et al. The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation 1993, 56(2):363-367.
26. Marvin M.R., Morton V. Glycemic control and organ transplantation. J Diabetes Sci Technol 2009, 3(6):1365-1372.
27. Powner D.J. Donor care before pancreatic tissue transplantation. Prog Transplant 2005, 15(2):129-136.